BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33661188)

  • 21. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
    Kim NH; Lee MY; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Yonsei Med J; 2017 Sep; 58(5):918-924. PubMed ID: 28792134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
    Wang P; Li C; Ma X; Gai X
    Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
    Elessawi DF; Alkady MM; Ibrahim IM
    Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
    Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
    Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer.
    Liu L; He Q; Li Y; Zhang B; Sun X; Shan J; Pan B; Zhang T; Zhao Z; Song X; Guo Y
    Clin Chim Acta; 2020 Oct; 509():36-42. PubMed ID: 32502495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
    Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
    Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
    Wang QJ; Zhang HC; Shen XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical significance of serum IGFBP-3 in colorectal cancer.
    Hou YL; Luo P; Ji GY; Chen H
    J Clin Lab Anal; 2019 Jul; 33(6):e22912. PubMed ID: 31218761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Karlíková M; Čurillová M; Pecen L; Karnos V; Karnos V; Topolčan O
    Anticancer Res; 2024 Jul; 44(7):3105-3113. PubMed ID: 38925804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
    Yin LK; Sun XQ; Mou DZ
    Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum CEA and CA19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
    Zhai H; Huang J; Yang C; Fu Y; Yang B
    Clin Lab; 2018 Mar; 64(3):351-356. PubMed ID: 29739122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction of a fecal protein Luminex liquid chip detection system for early diagnosis of colorectal tumors].
    Li J; Yin L; Zhang M; Xia Y; Zuo L; Liu M; Hu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1874-1880. PubMed ID: 38081604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Pasha HF; Radwan MI; Yehia AM; Toam MM
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
    Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
    Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.